Export 4 results:
Author Title [ Type(Desc)] Year
Filters: Author is King, Jacquie  [Clear All Filters]
Conference Paper
J. McNeely, McLeman, B., Gardner, T., Nesin, N., Farkas, S., Wahle, A., Pitts, S., Kline, M., King, J., Rosa, C., Marsch, L., Rotrosen, J., and Leah, H., “Successful Implementation of Substance Use Screening in Rural Federally-Qualified Health Centers Identified High Rates of Unhealthy Alcohol, Cannabis, and Tobacco Use”, in The College on Problems of Drug Dependence (CPDD), Minneapolis, MN, 2022.
Journal Article
J. D. Lee, Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., K Peavy, M., Ross, S., Salazar, D., Schkolnik, P., Shmueli-Blumberg, D., Stablein, D., Subramaniam, G., and Rotrosen, J., “Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.”, Lancet, vol. 391, no. 10118, pp. 309-318, 2018.
A. A. Aref, Scott, I. U., VanVeldhuisen, P. C., King, J., Ip, M. S., Blodi, B. A., and Oden, N. L., “Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial”, JAMA Ophthalmol, vol. 139, no. 12, pp. 1285-1291, 2021.
A. Hendrick, VanVeldhuisen, P. C., Scott, I. U., King, J., Blodi, B. A., Ip, M. S., Khurana, R. N., and Oden, N. L., “SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials.”, Am J Ophthalmol, vol. 222, pp. 185-193, 2020.